224 related articles for article (PubMed ID: 6547177)
1. Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone.
Shannon HE; Cone EJ; Gorodetzky CW
J Pharmacol Exp Ther; 1984 Jun; 229(3):768-74. PubMed ID: 6547177
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine.
France CP; Jacobson AE; Woods JH
J Pharmacol Exp Ther; 1984 Sep; 230(3):652-7. PubMed ID: 6206224
[TBL] [Abstract][Full Text] [Related]
3. Effects of buprenorphine on shock titration in squirrel monkeys.
Dykstra LA
J Pharmacol Exp Ther; 1985 Oct; 235(1):20-5. PubMed ID: 4045722
[TBL] [Abstract][Full Text] [Related]
4. Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
Picker MJ; Craft RM; Negus SS; Powell KR; Mattox SR; Jones SR; Hargrove BK; Dykstra LA
J Pharmacol Exp Ther; 1992 Nov; 263(2):668-81. PubMed ID: 1331411
[TBL] [Abstract][Full Text] [Related]
5. Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences.
Picker MJ; Yarbrough J; Hughes CE; Smith MA; Morgan D; Dykstra LA
J Pharmacol Exp Ther; 1993 Aug; 266(2):756-67. PubMed ID: 8394915
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
Shannon HE
J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus effects of the opioid antagonist diprenorphine in the squirrel monkey.
DeRossett SE; Holtzman SG
J Pharmacol Exp Ther; 1986 May; 237(2):437-44. PubMed ID: 3009783
[TBL] [Abstract][Full Text] [Related]
8. Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm.
Medvedev IO; Dravolina OA; Bespalov AY
J Pharmacol Exp Ther; 1998 Sep; 286(3):1260-8. PubMed ID: 9732387
[TBL] [Abstract][Full Text] [Related]
9. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
France CP; Woods JH
J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
[TBL] [Abstract][Full Text] [Related]
10. Measuring naloxone antagonism of discriminative opioid stimulus.
Krimmer EC; Barry H
Fed Proc; 1982 May; 41(7):2319-22. PubMed ID: 7042395
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
Schuh KJ; Walsh SL; Bigelow GE; Preston KL; Stitzer ML
J Pharmacol Exp Ther; 1996 Aug; 278(2):836-46. PubMed ID: 8768738
[TBL] [Abstract][Full Text] [Related]
12. Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys.
Pitts RC; Allen RM; Walker EA; Dykstra LA
J Pharmacol Exp Ther; 1998 Jun; 285(3):1197-206. PubMed ID: 9618423
[TBL] [Abstract][Full Text] [Related]
13. Behavioral effects of buprenorphine and diprenorphine under a multiple schedule of food presentation in squirrel monkeys.
Dykstra LA
J Pharmacol Exp Ther; 1983 Aug; 226(2):317-23. PubMed ID: 6875844
[TBL] [Abstract][Full Text] [Related]
14. Effects of naloxone, diprenorphine, buprenorphine and etorphine on unpunished and punished food-reinforced responding in the squirrel monkey.
DeRossett SE; Holtzman SG
J Pharmacol Exp Ther; 1984 Mar; 228(3):669-75. PubMed ID: 6707916
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
White DA; Holtzman SG
J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
[TBL] [Abstract][Full Text] [Related]
16. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
Walker EA; Makhay MM; House JD; Young AM
J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
[TBL] [Abstract][Full Text] [Related]
17. Stimulus properties of the narcotic antagonist pentazocine: similarity to morphine and antagonism by naloxone.
Kuhn DM; Greenberg I; Appel JB
J Pharmacol Exp Ther; 1976 Jan; 196(1):121-7. PubMed ID: 1246006
[TBL] [Abstract][Full Text] [Related]
18. Effects of opioids on accuracy of a fixed-ratio discrimination in monkeys and rats.
Moerschbaecher JM; Mastropaolo J; Winsauer PJ; Thompson DM
J Pharmacol Exp Ther; 1984 Sep; 230(3):541-9. PubMed ID: 6381692
[TBL] [Abstract][Full Text] [Related]
19. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
Picker MJ; Cook CD
Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
[TBL] [Abstract][Full Text] [Related]
20. Tolerance to morphine-like stimulus effects of mu opioid agonists.
Young AM; Kapitsopoulos G; Makhay MM
J Pharmacol Exp Ther; 1991 May; 257(2):795-805. PubMed ID: 2033521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
